class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
NOVEL FOOD requiring pre-market authorisation in EU — unapproved CBD supplements are not legally permitted to be sold in EU (EFSA 2019), UK (FSA 2020), Germany, Ireland. FDA has NOT approved CBD as dietary supplement in USA. Inhibits CYP3A4 and CYP2D6 — drug interaction potential. Can elevate liver enzymes.
Non-psychoactive cannabinoid from Cannabis sativa/hemp. Strong evidence as prescription medicine (Epidiolex) for refractory epilepsy. Evidence for anxiety and sleep is emerging in supplement doses.
Partial agonist at CB1 and CB2 receptors. Inhibits FAAH enzyme (increases endocannabinoids). Positive allosteric modulator of 5-HT1A receptors. Blocks T-type calcium channels. Multiple anti-inflammatory mechanisms.
Novel food requiring pre-market authorisation. Unapproved CBD supplements not legally permitted.
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)